Category :

Pharmaceuticals and Biotech Press Releases

US Surgeon General to Speak at APS Conference on Analgesic Trials

Lotus Clinical Research is pleased to announce that United States Surgeon General, VADM Jerome M. Adams, MD, MPH, will address the American Pain Society’s Third Annual Conference on Analgesic Trials (APS-CAT) and APS’ Scientific Summit on Sunday, March 4, 2018 at the…

Emerald Scientific to Host the 4TH ANNUAL EMERALD CONFERENCE Featuring 40+ Industry Experts Who Will Share the Latest Developments in Cannabis Science and Technology

Emerald Scientific to Host the 4TH ANNUAL EMERALD CONFERENCE Featuring 40+ Industry Experts Who Will Share the Latest Developments in Cannabis Science and Technology

​Emerald Scientific will host their fourth annual EMERALD CONFERENCE on February 15-16,  2018. Returning once again to the Hyatt Regency Mission Bay Spa and Marina in San Diego, California, leading experts in the industry will come together under one roof…

Ohio Science Could Spawn a New Sustainable Oil Boom

Ohio Science Could Spawn a New Sustainable Oil Boom

Agragen, LLC, a Cincinnati-based plant sciences company, predicts that the recent surge in oil prices will soon permit biofuels derived camelina oil to be on parity with petroleum-derived fuels in costs.  Sam Huttenbauer Jr., CEO of Agragen notes that “this…

The Role of Clinical Data, Content, and Workflow in Selecting Study Sites

The Role of Clinical Data, Content, and Workflow in Selecting Study Sites

On Wednesday, January 24, 2018 at 1 p.m. EST Xtalks will host a complimentary webinar with Veeva Systems and Paragon Solutions. Topics will include how to use content, data, and workflow together to significantly optimize the site selection and activation processes.…

Strategy for Launch Success: Strategic Considerations for a Commercially Successful Biopharmaceutical Launch in Europe, New Webinar Hosted by Xtalks

Strategy for Launch Success: Strategic Considerations for a Commercially Successful Biopharmaceutical Launch in Europe, New Webinar Hosted by Xtalks

​​Achieving product approval and reimbursement in Europe for a new biopharmaceutical product is essential to ensuring that the product is successful. However, approval and reimbursement by themselves are not sufficient to ensure a commercially successful European launch. There are several…

SaintyCo Publishes an Ultimate Guide on Wet Granulation on Their Website

SaintyCo Publishes an Ultimate Guide on Wet Granulation on Their Website

SaintyCo, a global leader in designing and manufacturing pharmaceutical equipment, today published an Ultimate Guide on Wet Granulation Process. This guide covers an in-depth analysis of both the high shear wet granulation process and machines. It is an all-in-one wet granulation…

Precision LTC Pharmacy Appoints Irien Moawad RPh as Executive Vice President of Client Management

Precision LTC Pharmacy Appoints Irien Moawad RPh as Executive Vice President of Client Management

​Precision LTC Pharmacy is pleased to announce the appointment of Irien Moawad RPh as Executive Vice President of Client Management. Moawad comes to Precision LTC Pharmacy with over 25 years of long-term care pharmacy experience and has recently served as…

OssDsign Accelerates Commercial Efforts in the US

OssDsign is active on the US neurosurgical implants market with its lead product OSSDSIGN Cranial PSI, a calcium-phosphate based implant for cranioplasty. Since March 2017, OssDsign has a commercial partnership with California-based Matador Medical Inc who acts as master distributor…

Addressing Platelet Refractoriness: Giving Hematology-Oncology Patients the Best Chance of Success, New Webinar Hosted by Xtalks

Addressing Platelet Refractoriness: Giving Hematology-Oncology Patients the Best Chance of Success, New Webinar Hosted by Xtalks

Join the live session on Wednesday, Jan. 24, 2018 with featured speaker Dr. Elisabeth Maurer-Spurej, Founder of LightIntegra Technology and principal inventor of ThromboLUX®. Dr. Maurer-Spurej will introduce activated platelets and their prevalence, discuss the impacts of activated platelet transfusions,…

Critical Success Factors in Reproductive Health Studies: Practical Tips for Minimizing Timelines, Risk and Costs, New Webinar Hosted by Xtalks

Critical Success Factors in Reproductive Health Studies: Practical Tips for Minimizing Timelines, Risk and Costs, New Webinar Hosted by Xtalks

In an Xtalks webinar upcoming on Wednesday, Jan. 24, 2018, featured speakers from Health Decisions, a leading women’s health specialty CRO, will address the challenges of conducting reproductive health studies efficiently and generating high-quality data to support successful regulatory submissions.…

VUV Analytics Announces Fuels and Petrochemical Milestones

VUV Analytics Announces Fuels and Petrochemical Milestones

VUV Analytics Inc., the leader in vacuum ultraviolet (VUV) absorption spectroscopy, today announced several fuels and petrochemical milestones ahead of the Gulf Coast Conference in Houston. “VUV Analytics is proud to announce that we more than tripled revenue in fuels and petrochemical…

Primetime announces a CRADA with NIST to characterize a Potentially New Class of Antimicrobials

Primetime Life Sciences, LLC has entered into a Collaborative Research and Development Agreement (CRADA) with the Biomolecular Measurement Division of the National Institute of Standards and Technology (NIST). Under this agreement, Primetime will collaborate with Dr. Prasad Reddy who is…

Sci-Engi-Medco Solutions Inc. Awarded SBIR Phase 1 NCI Contract to Study Its Lead Molecules in Preclinical Model of Triple Negative Breast Cancer

​​​Sci-Engi-Medco Solutions Inc. (SEMCO), a private cancer drug discovery and development company that explores its proprietary small molecule anticancer agent technology, announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase 1 contract from the National…

CRO Industry Veteran Mike Wilkinson Joins Patient iP as President and COO

​Patient iP, a health data and analytics company providing patient data insights to accelerate and transform clinical research, today announced that Mike Wilkinson has been named company President and Chief Operating Officer effective immediately.  He will report directly to Chairman,…

BioBridges Promotes Mary Bielefeld to Senior Financial Analyst

BioBridges Promotes Mary Bielefeld to Senior Financial Analyst

BioBridges, a Career Portfolio® Management company providing integrated services to the life sciences community, proudly announces the promotion of Mary Bielefeld to senior financial analyst. Mary joined the BioBridges community as an accounting assistant in 2014 and most recently held…

Bell Biosystems, Inc. Announces Pre-Clinical Results of Major in Vivo Safety Study Milestone

Bell Biosystems, Inc. (Bell) today presented the results of their latest pre-clinical safety study at the Biotech Showcase in San Francisco that runs concurrently with the annual J.P. Morgan Healthcare Conference. The study was designed in accordance with USP <151>…

NewLeaf Symbiotics Receives Second US Patent

The US Patent and Trademark Office has granted NewLeaf Symbiotics, a venture-funded agricultural biologicals company, US Patent No. 9,845,462, the second US patent to issue for NewLeaf's proprietary M-troph technology. M-trophs are beneficial bacteria that naturally colonize plants and stimulate…

Parnell Appoints Tony G Hartnell AM to Board of Directors

Parnell Appoints Tony G Hartnell AM to Board of Directors

Parnell Pharmaceuticals Holdings Ltd (OTC: PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal health solutions, today announced the appointment of Anthony G Hartnell AM to its Board of Directors. “We are indeed fortunate…

Bell Biosystems, Inc. to Present at the Biotech Showcase™ Annual Conference on January 8, 2018

Bell Biosystems, Inc. today announced that it will present at Biotech Showcase™ 2018, to be held Jan. 8–10 during the most important global annual healthcare meeting where commercial entities and the financial community come together to explore potential business opportunities…

Advanced BioMedical Technologies Inc. Commences Facility Upgrade

Advanced BioMedical Technologies Inc. Commences Facility Upgrade

​​Advanced Biomedical Technologies Inc. (OTCQB:ABMT), a developer and manufacturer of orthopaedic internal fixation devices, has announced the commencement of upgrading its facility in Shenzhen, China. The Company is renovating its Shenzhen GMP facility to meet new China Food and Drug Administration (“CFDA”) regulations and in…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login